Evidence map›Paper›PMID 33731848›Full record

ArticleLeukemia2021

EOMES is essential for antitumor activity of CD8

Laura Llaó-Cid, Philipp M Roessner, Vicente Chapaprieta, Selcen Öztürk, Tobias Roider, Marie Bordas, Ana Izcue, Dolors Colomer, Sascha Dietrich, Stephan Stilgenbauer and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 52 citations in OpenAlex.

  1. Influence of polyfunctional TbetFrontiers in immunology · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Laura Llaó-CidMolecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Philipp M RoessnerMolecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7061-5690
Vicente ChapaprietaInstitut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0002-4910-5394
Selcen ÖztürkMolecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tobias RoiderDepartment of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-6973-3531
Marie BordasMolecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ana IzcueMax-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-7974-7451
Dolors ColomerInstitut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0001-7486-8484
Sascha DietrichDepartment of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
Stephan StilgenbauerDepartment of Internal Medicine III, University of Ulm, Ulm, Germany.
Bola HannaMolecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
José Ignacio Martín-SuberoInstitut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0001-8809-5195
Martina SeiffertMolecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.seiffert@dkfz.de.ORCID http://orcid.org/0000-0001-5155-663X
German Cancer Research Center · DEHeidelberg University · DEConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Clínic de Barcelona · ESInstitució Catalana de Recerca i Estudis Avançats · ESUniversität Ulm · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies identified a single-nucleotide polymorphism (SNP) affecting the transcription factor Eomesodermin (EOMES) associated with a significantly increased risk to develop chronic lymphocytic leukemia (CLL). Epigenetic analyses, RNA sequencing, and flow cytometry revealed that EOMES is not expressed in CLL cells, but in CD8

Indexed as

AnimalsCase-Control StudiesCD8-Positive T-LymphocytesFemaleGenome-Wide Association StudyLeukemia, Lymphocytic, Chronic, B-CellLymph NodesMaleMiceMice, Inbred C57BLMice, KnockoutT-Box Domain ProteinsEOMES protein, humanEomes protein, mouseT-Box Domain Proteins

Identifiers

PMID33731848
PMCPMC8550953
OpenAlexW3137670646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.